发明名称 |
METHODS FOR DIAGNOSING AND MONITORING TREATMENT OF LEWY BODY DEMENTIA BY ASSESSING DOPAMINE TRANSPORTER LEVEL |
摘要 |
A method of diagnosing Lewy Body Dementia in a human patient by assessing the level of dopamine transporter in at least one region of the patient's central nervous system, where a lowered level of dopamine transporter in the patient is indicative of Lewy Body Dementia. In embodiments of the invention, assessment of dopamine transporter levels includes assessing binding of a dopamine transporter ligand to the dopamine transporters using PET or SPECT. |
申请公布号 |
US2016121003(A1) |
申请公布日期 |
2016.05.05 |
申请号 |
US201614992510 |
申请日期 |
2016.01.11 |
申请人 |
Alseres Pharmaceuticals, Inc. |
发明人 |
Hurtt Mark |
分类号 |
A61K51/04;A61K31/133;A61K31/445;A61K31/473;A61K31/27 |
主分类号 |
A61K51/04 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of treating Lewy Body Dementia in a human patient by the steps of:
(a) administering to a patient a labeled dopamine transporter ligand; and (b) assessing the amount of said labeled dopamine transporter ligand that is bound to dopamine transporter in at least one region of said patient's central nervous system, wherein a lowered level of said dopamine transporter in said patient is diagnostic of Lewy Body Dementia, and the step of treating patients diagnosed with Lewy Body Dimentia by administration of a therapeutic amount of tacrine or rivastagmine. |
地址 |
Hopkinton MA US |